Steven O'Day

4PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 28, 2026
Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.

|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.

Dhan Chand, David A Savitsky, Shanmugarajan Krishnan

|Dec 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Pamela Munster, Nicholas Iannotti, Daniel C Cho

|Jun 28, 2023
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial.

Espen B Ellingsen, Steven O'Day, Artur Mezheyeuski

Pageof 1

Frequent Collaborators

2 joint publications

Dhan Chand

2 joint publications

Wei Wu

2 joint publications

Joseph E Grossman

1 joint publications

David A Savitsky